Authors: CHARLTON PA FAINT RW BENT F BRYANS J CHICARELLIROBINSON I MACKIE I MACHIN S BEVAN P

Citation: Pa. Charlton et al., EVALUATION OF A LOW-MOLECULAR-WEIGHT MODULATOR OF HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY, Thrombosis and haemostasis, 75(5), 1996, pp. 808-815

Authors: BARNES CS FAINT RW DWYER MC CRITCHLEY DJP TEMPLETON D FOLKES AJ CHARLTON PA BEVAN P

Citation: Cs. Barnes et al., EFFECTS OF XR5118 ON PAI-1 AND TPA ACTIVITY AND ARTERIAL THROMBUS FORMATION IN THE ANESTHETIZED RAT, British Journal of Pharmacology, 118, 1996, pp. 97-97

Authors: CHARLTON PA FAINT RW BENT F BRYANS J MACKIE I MACHIN S BEVAN P

Citation: Pa. Charlton et al., A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INCREASE FIBRINOLYSIS AND PROTECT AGAINST THROMBUSFORMATION IN THE RAT, Thrombosis and haemostasis, 73(6), 1995, pp. 1005-1005

Authors: FAINT RW CHARLTON PA BENT F BRYANS J MACKIE I MACHIN S BEVAN P

Citation: Rw. Faint et al., THE IN-VITRO EVALUATION OF A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), Thrombosis and haemostasis, 73(6), 1995, pp. 1007-1007

Authors: CHARLTON PA BARNES CS BENT FM BRYANS JS FAINT RW FOLKES AJ MACHIN SJ MACKIE I BEVAN P

Citation: Pa. Charlton et al., EVALUATION OF A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1, Circulation, 92(8), 1995, pp. 2320-2320

Authors: PRICEJONES MJ CHARLTON PA BESSANT CM HARRISON TM DARKE BM LEES WE KAY J

Citation: Mj. Pricejones et al., ANALYSIS OF LATENT FORMS OF RENIN USING ANTIBODIES RAISED AGAINST THEPROPART SEGMENT OF HUMAN PRORENIN - VALIDATION WITH REPRESENTATIVE SAMPLES OF OVARIAN-CYST AND FOLLICULAR FLUIDS, Clinical and experimental hypertension, 15(4), 1993, pp. 619-640